Bullous systemic lupus erythematosus responding to dapsone.

Bullous systemic lupus erythematosus responding to dapsone. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Bullous systemic lupus erythematosus responding to dapsone. Abstract Text:

A 29-year-old woman with a 4-week history of systemic lupus erythematosus presented acutely with a severe generalized tense vesicular and bullous eruption with involvement of mucosal surfaces. At the time of her initial diagnosis of systemic lupus erythematosus, she had declined treatment, preferring to explore complementary medical therapies. Skin biopsy showed subepidermal blister formation with inflammation at the dermoepidermal junction. Direct immunofluorescence revealed strongly positive linear deposition of IgG and IgM, and positive linear granular deposition of IgA along the basement membrane zone. Electron microscopy showed that the level of the basement membrane split was below the lamina densa. A diagnosis of bullous systemic lupus erythematosus was made and dapsone was commenced, with a dramatic improvement in her skin eruption. The patient again declined further treatment of her systemic disease and sought complementary therapies, and subsequently presented with cerebral involvement.

Bullous systemic lupus erythematosus responding to dapsone. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Bullous systemic lupus erythematosus responding to dapsone. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Australasian journal of dermatology

VOLUME: 49

Page Numbers: 91-3

Journal Abbreviation: Australas. J. Dermatol.

ISSN: 1440-0960

DAY: 16

MONTH: May

YEAR: 2008

Bullous systemic lupus erythematosus responding to dapsone. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 135232

Bullous systemic lupus erythematosus responding to dapsone. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Bullous systemic lupus erythematosus responding to dapsone. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Bullous systemic lupus erythematosus responding to dapsone.

AFFILIATION: Department of Dermatology, Greenlane Clinical Centre, Auckland District Health Board, Auckland, New Zealand. mathewlu@med.umich.edu

Country: Australia

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Australas J Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Bullous systemic lupus erythematosus responding to dapsone Related Publications

• Allergic contact dermatitis to all three classes of local anaesthetic.
• Alzheimer's disease drug development in 2008 and beyond: problems and opportunities.
• An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution.
• Apoptotic and behavioral sequelae of mild brain trauma in mice.
• Bullous systemic lupus erythematosus responding to dapsone.
• Christman-factor (factor IX) deficiency produced by concurrent administration of heparin with coumarin drugs.
• DIBENZO(B,E)(1,4)DIAZEPINES.
• Dietary fat and coronary disease.
• Differential effects of two hexahydropyrroloindole carbamate-based anticholinesterase drugs on the amyloid beta protein pathway involved in Alzheimer's disease.
• Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy.
• Inhibition of fibrinolysis by alimentary lipaemia.
• Kinetics of human serum butyrylcholinesterase inhibition by a novel experimental Alzheimer therapeutic, dihydrobenzodioxepine cymserine.
• LOUIS GREIG.
• Letter: Effect of natural oestrogens on coagulation.
• Modern architecture.
• Neurine, an acetylcholine autolysis product, elevates secreted amyloid-beta protein precursor and amyloid-beta peptide levels, and lowers neuronal cell viability in culture: a role in Alzheimer's disease?
• Post-operative thrombosis; investigation of a proposed test for its prediction.
• Practical points.
• Prezygotic reproductive isolation between Saccharomyces cerevisiae and Saccharomyces paradoxus.
• Recurrent pyogenic cholangitis with hepatolithiasis-the role of surgical therapy in north america.
• Results of surgery for ingrowing toenails.
• Soccer half-time strategy influences thermoregulation and endurance performance.
• TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets.
• Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysis.
• The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice.
• The influence of soccer-specific fatigue on peak isokinetic torque production of the knee flexors and extensors.
• The inhibition of hexokinase by amidone (2-dimethylamino-4,4-diphenylheptanone-5-hydrochloride).
• Water-jet dissection for parenchymal division during hepatectomy.